Comparison of speciated arsenic levels in the liver and brain of mice between arsenate and arsenite exposure at the early life

Environmental Toxicology

Volumn 29, Issue 7, 2014, Pages 797-803

  Lu, Chunwei ^a   Zhao, Fenghong ^a   Sun, Di ^a   Zhong, Yuan ^a   Yu, Xiaoyun ^a   Li, Gexin ^a   Lv, Xiuqiang ^a   Sun, Guifan ^a   Jin, Yaping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Arsenate; Arsenic species; Arsenite; Early life exposure; Mice

Indexed keywords

ALKYLATION; ARSENIC;

ARSENATE; ARSENIC SPECIES; ARSENITE; EARLY LIFE; MICE;

MAMMALS;

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; CACODYLIC ACID; DRINKING WATER;

ARSENATE; ARSENITE; BIOACCUMULATION; BRAIN; COMPARATIVE STUDY; CONCENTRATION (COMPOSITION); DEVELOPMENTAL STAGE; HEALTH RISK; METHYLATION; POLLUTION EXPOSURE; RODENT; SPECIATION (CHEMISTRY); VOLATILE SUBSTANCE;

ANIMAL EXPERIMENT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; LACTATION; METHYLATION; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; WEANING;

MUS;

ARSENATE; ARSENIC SPECIES; ARSENITE; EARLY LIFE EXPOSURE; MICE;

ANIMALS; ANIMALS, NEWBORN; ARSENATES; ARSENIC; ARSENITES; BRAIN; CACODYLIC ACID; FEMALE; LACTATION; LIVER; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; METHYLATION; MICE; PREGNANCY; TISSUE DISTRIBUTION; WATER POLLUTANTS, CHEMICAL;

EID: 84901851459     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.21808     Document Type: Article

References (48)

1. Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML.2003.Oxidation and detoxification of trivalent arsenic species.Toxicol Appl Pharmacol193:1-8.
2. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano JH, Ahsan H.2009.Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: Review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.Toxicol Appl Pharmacol239:184-192.
3. Chowdhury UK, Zakharyan RA, Hernandez A, Avram MD, Kopplin MJ, Aposhian HV.2006.Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration.Toxicol Appl Pharmacol216:446-457.
4. Concha G, Nermell B, Vahter MV.1998.Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina.Environ Health Perspect106:355-359.
5. Devesa V, Adair BM, Liu J, Waalkes MP, Diwan BA, Styblo M, Thomas DJ.2006.Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite.Toxicology224:147-155.
6. Fangstrom B, Moore S, Nermell B, Kuenstl L, Goessler W, Grander M, Kabir I, Palm B, Arifeen SE, Vahter M.2008.Breast-feeding protects against arsenic exposure in Bangladeshi infants.Environ Health Perspect116:963-969.
7. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM.2007.Arsenic methylation capability and hypertension risk in subjects living in arseniasishyperendemic areas in southwestern Taiwan.Toxicol Appl Pharmacol218:135-142.
8. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Razo LM, Thomas DJ.2003.Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.Toxicol Appl Pharmacol191:202-210.
9. Jin Y, Xi S, Li X, Lu C, Li G, Xu Y, Qv C, Niu Y, Sun G.2006.Arsenic speciation transported through the placenta from mother mice to their newborn pups.Environ Res101:349-355.
10. Jin Y, Wang G, Zhao F, Liao Y, Sun D, Zhong Y, Yu X, Lv X, Li G, Sun G.2010.Distribution of speciated arsenicals in mice exposed to arsenite at the early life.Ecotoxicol Environ Saf73:1323-1326.
11. Juárez-Reyes A, Jiménez-Capdeville ME, Delgado JM, Ortiz-Pérez D.2009.Time course of arsenic species in the brain and liver of mice after oral administration of arsenate.Arch Toxicol83:557-563.
12. Kenyon EM, Del-Razo LM, Hughes MF, Kitchin KT.2005a.An integrated pharmacokinetic and pharmacodynamic study of arsenite action. 2. Heme oxygenase induction in mice.Toxicology206:389-401.
13. Kenyon EM, Del-Razo LM, Hughes MF.2005b.Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.Toxicol Sci85:468-475.
14. Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, Clewell HJ, Yager JW.2008.Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.Toxicol Appl Pharmacol232:448-455.
15. Kitchin KT, Wallace K.2008.The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity.J Inorg Biochem102:532-539.
16. Kitchin KT, Del-Razo LM, Brown JL, Anderson WL, Kenyon EM.1999.An integrated pharmacokinetic and pharmacodynamic study of arsenite action. 1. Heme oxygenase induction in rats.Teratogen Carcinogen Mutagen19:385-402.
17. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH.2008.Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile.Cancer Epidemiol Biomarkers Prev17:1982-1987.
18. Lindberg AL, Rahman M, Persson LA, Vahter M.2008.The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure.Toxicol Appl Pharmacol230:9-16.
19. Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergeld EK.2003.Variability in human metabolism of arsenic.Environ Res92:85-91.
20. Messens J, Silver S.2006.Arsenate reduction: Thiol cascade chemistry with convergent evolution.J Mol Biol362:1-17.
21. O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R.2011.Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: A Project FRONTIER study.Int J Environ Res Public Health8:861-874.
22. Rahman MM, Ng JC, Naidu R.2009.Chronic exposure of arsenic via drinking water and its adverse health impacts on humans.Environ Geochem Health31:189-200.
23. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA, Arifeen SE, Moore S, Vahter M.2009.Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh.Toxicol Lett185:197-202.
24. Rodríguez VM, Del-Razo LM, Limón-Pacheco JH, Giordano M, Sánchez-Peña LC, Uribe-Querol E, Gutiérrez-Ospina G, Gonsebatt ME.2005.Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver.Toxicol Sci84:157-166.
25. Rosen BP.2002.Biochemistry of arsenic detoxification.FEBS Lett529:86-92.
26. Sakurai T, Kojima C, Kobayashi Y, Hirano S, Sakurai MH, Waalkes MP, Himeno S.2006.Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).Br J Pharmacol149:888-897.
27. Sampayo RA, Zakharyan RA, Healy SM, Aposhian HV.2000.Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue.Chem Res Toxicol13:1181-1186.
28. Sánchez-Peña LC, Petrosyan P, Morales M, González NB, Gutiérrez-Ospina G, Del-Razo LM, Gonsebatt ME.2010.Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite.Environ Res110:428-434.
29. Schwerdtle T, Walter I, Mackiw I, Hartwig A.2003.Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA.Carcinogenesis24:967-974.
30. Shen J, Liu J, Xie Y, Diwan BA, Waalkes MP.2007.Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure.Toxicol Sci95:313-320.
31. States JC, Srivastava S, Chen Y, Barchowsky A.2009.Arsenic and cardiovascular disease.Toxicol Sci107:312-323.
32. Styblo M, Yamauchi H, Thomas DJ.1995.Comparative in vitro methylation of trivalentand pentavalent arsenicals.Toxicol Appl Pharmacol135:172-178.
33. Thomas DJ.2007.Molecular processes in cellular arsenic metabolism.Toxicol Appl Pharmacol222:365-373.
34. Thomas DJ, Waters SB, Styblo M.2004.Elucidating the pathway for arsenic methylation.Toxicol Appl Pharmacol198:319-326.
35. Tseng CH.2007.Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans.J Environ Biol28:349-357.
36. Vahter M.2002.Mechanisms of arsenic biotransformation.Toxicology181/182:211-217.
37. Vahter M.2008.Health effects of early life exposure to arsenic.Basic Clin Pharmacol Toxicol102:204-211.
38. Vahter M.2009.Effects of arsenic on maternal and fetal health.Annu Rev Nutr29:381-399.
39. Waalkes MP, Liu J.2008.Early-life arsenic exposure: methylation capacity and beyond.Environ Health Perspect116:A104.
40. Waalkes MP, Ward JM, Liu J, Diwan BA.2003.Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.Toxicol Appl Pharmacol186:7-17.
41. Waalkes MP, Liu J, Ward JM, Diwan BA, 2004.Animals models for arsenic carcinogenesis: Inorganic arsenic a transplacental carcinogen in mice.Toxicol Appl Pharmacol198:377-384.
42. Waalkes MP, Liu J, Diwan BA.2007.Transplacental arsenic carcinogenesis in mice.Toxicol Appl Pharmacol222:271-280.
43. Wang JP, Qi L, Moore MR, Ng JC.2002.A review of animal models for the study of arsenic carcinogenesis.Toxicol Lett133:17-32.
44. Wang SX, Wang ZH, Cheng XT, Li J, Sang ZP, Zhang XD, Han LL, Qiao XY, Wu ZM, Wang ZQ.2007a.Arsenic and fluoride exposure in drinking water: Children's IQ and growth in Shanyin county, Shanxi province, China.Environ Health Perspect115:643-647.
45. Wang TC, Jan KY, Wang AS, Gurr JR.2007b.Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells.Mutat Res615:75-86.
46. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van-Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Hussain I, Momotaj H, Graziano JH.2004.Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh.Environ Health Perspect112:1329-1333.
47. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, van-Geen A, Slavkovich V, Loiacono NJ, Levy D, Cheng Z, Graziano JH.2007.Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh.Environ Health Perspect115:285-289.
48. Zakharyan RA, Tsaprailis G, Chowdhury UK, Hernandez A, Aposhian HV.2005.Interactions of sodium selenite, glutathione, arsenic species, and omega class human glutathione transferase.Chem Res Toxicol18:1287-1295.